常茂生物：截至二零二四年十二月三十一日止年度全年业绩公告及根据上市规则第13.19条所作的披露

954 298,793338,317 1,249,7581,242,496 109,800250,410 61,868265,669 10514,740242,203 604,551325,238 666,419590,907 1,249,7581,242,496 1 H 1228213034 622 68,251,00032,317,000305,758,000524,540,000514,740,00057,963,000 282,634,000206,474,000 • •409,000,000162,666,000 • • ••(1)(2)•• (a) •–1•5•–16•–77 (b) •21•97•11•18•19 2 8 950,745,000903,495,000 20,490,00035,115,0004%6%)10% (i)724,000(ii)3,8675,930 (a) (a) 6 15%25% (a)200%200% 7 68,243,00086,057,000529,700,000529,700,000 8 40,787,0000.077 (a)30210 (b) (a)69,715,00071,222,00078,298,000 (b)60%70%70%206,474,0001 76,16077,976128,498 (c)(d)9,422,000215,806,000(e)4.4%4.4%3.1%3.4% 11 (a) (b)(c) 584,794,000637,078,0008%68,243,00021% 1. 18% 2. 8%9% 3. “3.0” 4. 14% 5. 44301411 14131 6. 1. 2. 3. 4. ESG 584,794,000637,078,0002.9%4.1% (1) (2) 81,019,00083,307,000 7,945,0006,745,000 566,0001,112,000 10,514,0006,532,000 669,00027,938,000 15%25%23,652,0006 68,243,00086,057,000 30.8%27.0%69.2%73.0% 524,540,000492,613,00069,715,00071,222,00078,298,00010 34,719,00086,586,000 53.3%47.6%57,963,00089,554,000 58263198,884,00089,667,000 40,000,000 (a)5%(b)5%(c)5% 13.19 282,634,000 68,251,00032,317,000305,758,000524,540,000514,740,00057,963,000 1206,474,000 1 268,251,00032,317,000305,758,000524,540,000514,740,00057,963,000282,634,0002 XV(a)XV78(b)352(c)(d)622 (a)96,500A135,000,000170,000A100,000B70%2,500,00012,184,000H52,000H(b) (b)73,500A53,000B135,000,000170,000A100,000B30%2,500,00052,000H12,184,000H(a) (c)2,000B135,000,000170,000A100,000B200,00067,500,0006,750,000 (d)380,00067,500,0006,750,0002,000B135,000,000170,000A100,000B (e)66,000,0003,774,000H(f)220,00067,500,0006,750,000(g)800B135,000,000170,000A100,000B120,00067,500,0006,750,000(h)2,500,000(i)343,500,000(j)183,700,000H XV(a)XV78(b)352(c)(d)622 XV23 XV23336 (a)66,000,0003,774,000H(b)100%62,500,000(c)62.3%100%62,500,000(d)100%62.3%100%62,500,000(e)343,500,000(f)183,700,000H XV23336 H(a)(b)(c) (a)0.10(b)0.10(c)0.10 HH H (a)(b)(c)(d) C1 3.13 C1 H C3